Kenadion Injection (Phytomenadione) 0.5 ml is a Vitamin K1 formulation used to prevent and treat bleeding disorders caused by Vitamin K deficiency. It plays a vital role in blood clotting by assisting the liver in producing clotting factors. Commonly administered to newborns to prevent hemorrhagic disease and to patients on anticoagulant therapy or with liver disorders, Kenadion ensures proper coagulation and minimizes the risk of uncontrolled bleeding.

• Prevents and treats Vitamin K deficiency-related bleeding

• Essential for proper blood clotting and coagulation

• Commonly used in newborns to prevent hemorrhagic disease

• Supports patients with liver dysfunction or malabsorption syndromes

• Reverses the effects of oral anticoagulants in cases of overdose

Kenadion Injection is administered by a healthcare professional via intramuscular (IM) or intravenous (IV) route, depending on the clinical need. Dosage and method of administration vary based on age, condition, and severity of deficiency.

• Newborns: Typically 0.5 to 1 mg IM at birth for prophylaxis

• Adults and children: Dose depends on the severity of Vitamin K deficiency or bleeding condition

• Repeat dosing may be necessary in some cases

• Must be administered under medical supervision only

• Inform your doctor of any allergies, liver disease, or ongoing medications

• Use cautiously in patients with G6PD deficiency or known hypersensitivity to Vitamin K

• Not intended for self-administration

• Observe for any allergic reaction during administration

Most patients tolerate Kenadion well. Potential side effects include:

• Pain or swelling at the injection site

• Dizziness or flushing

• Rare allergic reactions such as rash, itching, or anaphylaxis

• Rapid IV injection may cause cardiovascular reactions; always administer slowly

Seek medical help immediately if any serious side effects occur.